Legal Representation
Attorney
Erik Eglite
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 15, 2024 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Aug 15, 2024 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
| May 1, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| May 1, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| May 1, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 25, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 25, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 29, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research services; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
First Use Anywhere:
Jan 2, 2022
First Use in Commerce:
Jan 2, 2022
Classification
International Classes
042